Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development expenses	$ 5,843,686	$ 5,161,315
General and administrative expenses	3,578,728	3,317,907
Total operating expenses	9,422,414	8,479,222
Loss from operations	(9,422,414)	(8,479,222)
Interest income (expense), net:
Interest income	729,341	5,700
Interest expense	(966,845)	0
Interest income (expense), net	(237,504)	5,700
Net loss	(9,659,918)	(8,473,522)
Comprehensive loss	$ (9,659,918)	$ (8,473,522)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.32)	$ (0.32)
Net loss per share, diluted (in dollars per share)	$ (0.32)	$ (0.32)
Weighted average common shares outstanding, basic (in shares)	30,428,053	26,161,156
Weighted average common shares outstanding, diluted (in shares)	30,428,053	26,161,156